Syrma SGS Technology Limited announced the passing of Mr. Satyendra Johari, Chairman and Managing Director of its subsidiary Syrma Johari Medtech Limited (SJML), on August 8, 2025. Mr. Johari, who was 77 years old, was the founder of SJML, formerly known as Johari Digital Healthcare Limited.

Company's Response

In a regulatory filing dated August 10, 2025, Syrma SGS Technology Limited informed the stock exchanges about the sad demise of Mr. Johari. The company expressed its deepest condolences to his family and loved ones.

Leadership Transition

The board of SJML will take necessary steps to ensure continuity of operations following Mr. Johari's passing. This move is crucial to maintain the stability and ongoing business activities of the subsidiary.

About Syrma Johari Medtech Limited

Syrma Johari Medtech Limited, a subsidiary of Syrma SGS Technology Limited, was formerly known as Johari Digital Healthcare Limited. The company's operations are in the healthcare technology sector, reflecting its origins under Mr. Johari's leadership.

Regulatory Compliance

The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Syrma SGS Technology Limited has provided the necessary details as per the SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

As the technology and healthcare sectors continue to evolve, the legacy of Mr. Satyendra Johari and his contributions to Syrma Johari Medtech Limited will undoubtedly be remembered. The focus now turns to the company's future leadership and its continued operations in the dynamic medtech industry.

Syrma SGS Technology , a prominent player in the electronics manufacturing services sector, has embarked on a significant capital raising initiative through a Qualified Institutional Placement (QIP). The company aims to raise Rs 1,000 crore in a move that will result in a 7.43% equity dilution of its post-issue outstanding equity capital.

QIP Details

The QIP, which opened on Thursday and is set to close on Friday, has set a floor price of Rs 735.61 per share. This represents a modest 1.60% discount from the previous closing price of Rs 747.60 on the National Stock Exchange (NSE). Dam Capital has been appointed as the book-running lead manager for this placement.

Investors participating in the QIP can expect trading approval for the shares on August 14, with institutional buyers receiving shares in their demat accounts on the same day. Trading of these newly issued shares is scheduled to commence on August 18.

Strong Quarterly Performance

Alongside this capital raising initiative, Syrma SGS Technology has reported impressive financial results for the recent quarter:

The company's consolidated net profit surged by an impressive 157.51%, rising to Rs 49.70 crore from Rs 19.30 crore in the previous quarter. This substantial increase is attributed to improved operating leverage.

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) also saw a significant boost, increasing by 90.75% to Rs 86.60 crore from Rs 45.40 crore. Moreover, the profit margin experienced a notable jump of 530 basis points, reaching 9.20%.

It's worth noting that despite these positive indicators, the consolidated revenue for the quarter declined by 18.62%, dropping to Rs 944.00 crore from Rs 1,160.00 crore in the previous quarter.

Regulatory Compliance

In compliance with regulatory requirements, Syrma SGS Technology has filed the preliminary placement document with both the BSE Limited and National Stock Exchange of India Limited. The company has also implemented measures to ensure fair trading practices, including the closure of the trading window for designated persons until 48 hours after the determination of the issue price.

As Syrma SGS Technology moves forward with this significant capital raising initiative, investors and market watchers will be keenly observing its impact on the company's growth trajectory and market position in the electronics manufacturing services sector.